...Health info at your doorstep

Day: 4 February 2021

How The COVID-19 Vaccines Compare To Each Other

How The COVID-19 Vaccines Compare To Each Other

NEWS
  In the race to end the coronavirus  pandemic, the more safe, effective vaccines we have available, the sooner we’ll be able to climb out of this mess. So far, five vaccines — produced by Moderna, Pfizer, Novavax, Johnson & Johnson and AstraZeneca — are the front-runners. In the coming months, these vaccines will not only save tons of lives, but they will also alleviate some of the overwhelming pressure on the health care system and provide our frontline workers with some much-needed rest. Below, where we dissect the leading vaccines, you’ll notice the shots’ efficacy levels range from 66% to 95%. While that may seem like a huge gap, it’s worth noting that comparing vaccine efficacy levels is kind of like “comparing apples to oranges,” according to Onyema Ogbuagu , a
COVAX Releases List of COVID-19 Vaccine Recipients, Gives Nigeria 16m Doses

COVAX Releases List of COVID-19 Vaccine Recipients, Gives Nigeria 16m Doses

NEWS
  ·         India tops list ·         First deliveries expected late February   The COVAX programme to ensure equitable worldwide access to COVID-19 vaccines on Wednesday published its first distribution list, with enough doses for countries to immunise more than three per cent of their populations by mid-2021. The distribution plan comes with lower-income countries falling behind in the vaccination race — a problem COVAX was set up to address. It broke down how the programme’s initial 337.2 million doses will be distributed, with first deliveries expected in late February. Some 145 countries are set to receive enough doses to immunise 3.3 per cent of their collective population by mid-2021, COVAX said. A statement said the initial distribution was in